Enhancement of Gene Expression by Polyamidoamine Dendrimer Conjugates with α-, β-, and γ-Cyclodextrins
- 22 June 2001
- journal article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 12 (4), 476-484
- https://doi.org/10.1021/bc000111n
Abstract
To improve the transfection efficiency of nonviral vector, we synthesized the starburst polyamidoamine dendrimer conjugates with alpha-, beta-, and gamma-cyclodextrins (CDE conjugates), expecting the synergistic effect of dendrimer and cyclodextrins (CyDs). The (1)H NMR spectroscopic data indicated that alpha-, beta-, and gamma-CyDs are covalently bound to dendrimer in a molar ratio of 1:1. The agarose gel electrophoretic studies revealed that CDE conjugates formed the complexes with plasmid DNA (pDNA) and protected the degradation of pDNA by DNase I in the same manner as dendrimer. CDE conjugates showed a potent luciferase gene expression, especially in the dendrimer conjugate with alpha-CyD (alpha-CDE conjugate) which provided the greatest transfection activity (approximately 100 times higher than those of dendrimer alone and of the physical mixture of dendrimer and alpha-CyD) in NIH3T3 and RAW264.7 cells. In addition, the gene transfer activity of alpha-CDE conjugate was superior to that of Lipofectin. The enhancing gene transfer effect of alpha-CDE conjugate may be attributable to not only increasing the cellular association, but also changing the intracellular trafficking of pDNA. These findings suggest that alpha-CDE conjugate could be a new preferable nonviral vector of pDNA.Keywords
This publication has 17 references indexed in Scilit:
- β-Cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cellsBioorganic & Medicinal Chemistry Letters, 2000
- Interactions of Cyclodextrins with Dipalmitoyl, Distearoyl, and Dimyristoyl Phosphatidyl Choline Liposomes. A Study by Leakage of Carboxyfluorescein in Inner Aqueous Phase of Unilamellar Liposomes.CHEMICAL & PHARMACEUTICAL BULLETIN, 2000
- Cyclodextrins in peptide and protein deliveryAdvanced Drug Delivery Reviews, 1999
- Colon-Specific Drug Delivery Based on a Cyclodextrin Prodrug: Release Behavior of Biphenylylacetic Acid from Its Cyclodextrin Conjugates in Rat Intestinal Tracts after Oral AdministrationJournal of Pharmaceutical Sciences, 1998
- Efficacy, Safety and Mechanism of Cyclodextrins as Absorption Enhancers in Nasal Delivery of Peptide and Protein DrugsJournal of Drug Targeting, 1998
- 6A-O-[(4-Biphenylyl)acetyl]-α-, -β-, and -γ-cyclodextrins and 6A-Deoxy-6A-[[(4-biphenylyl)acetyl]amino]-α-, -β-, and -γ-cyclodextrins: Potential Prodrugs for Colon-Specific DeliveryJournal of Medicinal Chemistry, 1997
- Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety EvaluationJournal of Pharmaceutical Sciences, 1997
- Cyclodextrins as templates for the presentation of protease inhibitorsFEBS Letters, 1996
- Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic MatterAngewandte Chemie-International Edition, 1990
- Serum alkaline DNase activity in normal or nonhospitalised individualsClinica Chimica Acta; International Journal of Clinical Chemistry, 1989